Thus, our study established a critical role of FTO in both the insulin-regulated hepatic lipogenesis and the pathogenesis of NAFLD and provided a potential strategy for treating NAFLD. This evidence concerns the gene FTO and metabolic dysfunction-associated steatotic liver disease.